Skip to main content
OpenTrials

Clinical trial condition

COVID-19

Explore clinical trials studying COVID-19. Study availability and eligibility vary by location and protocol.

1,904 public trials 96 recruiting studies
Refine in advanced search Browse all conditions

COVID-19 trial results

Completed

Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19

NCT04780035

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • State Budgetary Healthcare Institution of the Moscow region - Krasnogorsk City Hospital # 1 (short name: SBHI MR KCH # 1) Krasnogorsk, Moscow Oblast, Russia
  • Federal State Autonomous Educational Institution of Higher Education - Immanuel Kant Baltic University (short name: FSAEIHE- I. Kant Baltic Federal University) Kaliningrad, Russia
  • State Autonomous Healthcare Institution - Clinical City Hospital # 7 of Kazan (short name: SAHI CCH # 7) Kazan', Russia
  • Federal State Budgetary Institution - N.I. Pirogov National Medical and Surgical Center, Ministry of Health of the Russian Federation (short name: FSBI - N.I. Pirogov NMSC, Ministry of Health of the Russian Federation) Moscow, Russia
View Trial Details
Completed

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

NCT04401579

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • University of Alabama at Birmingham School of Medicine - Infectious Disease Birmingham, Alabama, United States
  • University of California San Diego Health - Jacobs Medical Center La Jolla, California, United States
  • University of California Los Angeles Medical Center - Westwood Clinic Los Angeles, California, United States
  • University of California Irvine Medical Center - Infectious Disease Orange, California, United States
View all 71 locations
View Trial Details
Completed

Adaptive COVID-19 Treatment Trial (ACTT)

NCT04280705

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • University of Alabama at Birmingham School of Medicine - Infectious Disease Birmingham, Alabama, United States
  • University of California San Diego Health - Jacobs Medical Center La Jolla, California, United States
  • University of California Los Angeles Medical Center - Westwood Clinic Los Angeles, California, United States
  • University of California Irvine Medical Center - Infectious Disease Orange, California, United States
View all 60 locations
View Trial Details
Completed

Adaptive COVID-19 Treatment Trial 3 (ACTT-3)

NCT04492475

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • University of Alabama at Birmingham School of Medicine - Infectious Disease Birmingham, Alabama, United States
  • UCSF Fresno Center for Medical Education and Research - Clinical Research Center Fresno, California, United States
  • University of California San Diego Health - Jacobs Medical Center La Jolla, California, United States
  • University of California Los Angeles Medical Center - Westwood Clinic Los Angeles, California, United States
View all 64 locations
View Trial Details
Completed

Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)

NCT04466540

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • Centro de Pesquisas Clínicas Dr. Marco Mota HCOR Maceió, Alagoas, Brazil
  • Hospital Maternidade São Vicente de Paulo Barbalha, Ceará, Brazil
  • Hospital Unimed Cariri Juazeiro do Norte, Ceará, Brazil
  • Unimed Sul Capixaba Cachoeiro de Itapemirim, Espírito Santo, Brazil
View all 69 locations
View Trial Details
Completed

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

NCT04539262

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • The Institute for Liver Health Mesa, Arizona, United States
  • The Institute for Liver Health Tucson, Arizona, United States
  • Franco Felizarta, MD Bakersfield, California, United States
  • Aurora FDRC Inc. Costa Mesa, California, United States
View all 28 locations
View Trial Details

Related conditions